Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Bulletin Du Cancer
|
January 1, 1995
[CD44 expression: a new prognostic factor in neuroblastoma]
V Combaret, C Lasset, R Bouvier, et al.
Blood
|
October 1, 1993
Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor
J Y Blay, N Burdin, F Rousset, et al.
Blood
|
December 9, 1998
Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor
C Menetrier-Caux, G Montmain, M C Dieu, et al.
Diabetes & Metabolism
|
January 30, 2007
MnTMPyP, a metalloporphyrin-based superoxide dismutase/catalase mimetic, protects INS-1 cells and human pancreatic islets from an in vitro oxidative challenge
C Moriscot, S Candel, V Sauret, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1995
Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors
V Combaret, C Lasset, D Frappaz, et al.
British Journal of Haematology
|
September 1, 1986
Bone marrow purging procedure in Burkitt lymphoma with monoclonal antibodies and complement: quantification by a liquid cell culture monitoring system
M C Favrot, I Philip, T Philip, et al.
Cancer Research
|
December 1, 1996
Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors
N Voorzanger, R Touitou, E Garcia, et al.
Blood Reviews
|
June 1, 1991
Management of pediatric non-Hodgkin's lymphoma
J Y Blay, D Louis, E Bouffet, et al.
International Journal of Cancer
|
April 10, 1995
Sensitive detection of numerical and structural aberrations of chromosome 1 in neuroblastoma by interphase fluorescence in situ hybridization. Comparison with restriction fragment length polymorphism and conventional cytogenetic analyses
V Combaret, C Turc-Carel, P Thiesse, et al.
Molecular Biotherapy
|
March 1, 1990
Lymphokine-activated killer cell expansion for clinical trials of adoptive immunotherapy with interleukin-2: optimization of the culture technique
M C Favrot, C Coze, V Combaret, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Bulletin Du Cancer
|
January 1, 1995
[CD44 expression: a new prognostic factor in neuroblastoma]
V Combaret, C Lasset, R Bouvier, et al.
Blood
|
October 1, 1993
Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor
J Y Blay, N Burdin, F Rousset, et al.
Blood
|
December 9, 1998
Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor
C Menetrier-Caux, G Montmain, M C Dieu, et al.
Diabetes & Metabolism
|
January 30, 2007
MnTMPyP, a metalloporphyrin-based superoxide dismutase/catalase mimetic, protects INS-1 cells and human pancreatic islets from an in vitro oxidative challenge
C Moriscot, S Candel, V Sauret, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1995
Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors
V Combaret, C Lasset, D Frappaz, et al.
British Journal of Haematology
|
September 1, 1986
Bone marrow purging procedure in Burkitt lymphoma with monoclonal antibodies and complement: quantification by a liquid cell culture monitoring system
M C Favrot, I Philip, T Philip, et al.
Cancer Research
|
December 1, 1996
Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors
N Voorzanger, R Touitou, E Garcia, et al.
Blood Reviews
|
June 1, 1991
Management of pediatric non-Hodgkin's lymphoma
J Y Blay, D Louis, E Bouffet, et al.
International Journal of Cancer
|
April 10, 1995
Sensitive detection of numerical and structural aberrations of chromosome 1 in neuroblastoma by interphase fluorescence in situ hybridization. Comparison with restriction fragment length polymorphism and conventional cytogenetic analyses
V Combaret, C Turc-Carel, P Thiesse, et al.
Molecular Biotherapy
|
March 1, 1990
Lymphokine-activated killer cell expansion for clinical trials of adoptive immunotherapy with interleukin-2: optimization of the culture technique
M C Favrot, C Coze, V Combaret, et al.
Page
of 8